Regional surgical quality collaborative significantly improves surgical outcomes and reduces cost

January 23, 2012 in Other

A new study published online today in the Journal of the American College of Surgeons finds hospitals participating in a regional collaborative of the American College of Surgeon's National Surgical Quality Improvement Program (ACS NSQIP®), achieved substantial improvements in surgical outcomes, such as reducing the rates of acute renal failure and surgical site infections. The collaborative also saved $2,197,543 per 10,000 general and vascular surgery cases when comparing results from 2010 with results from 2009. ACS NSQIP is the leading nationally validated, risk-adjusted, outcomes-based program to measure and improve the quality of surgical care in the private sector.

The Tennessee Collaborative (TSQC) collected ACS NSQIP data from 10 participating hospitals to examine and identify trends in surgical outcomes and evaluate best practices among these hospitals. The study evaluated 20 categories of postoperative complications, 30-day mortality rates, and hospital costs associated with postoperative complications in a total of 14,205 surgical cases in 2009 and 14,901 surgical cases in 2010.

"We demonstrated that hospitals in a collaborative can greatly improve their quality by sharing data, comparing results, and evaluating best practices and process improvement approaches with their peers," said Joseph B. Cofer MD, FACS, statewide surgeon champion for the collaborative, author of the study and professor of surgery and surgery residency program director, Department of Surgery, at the University of Tennessee College of Medicine-Chattanooga.

The Tennessee collaborative saw improvements in such procedures as acute renal failure (25.1% reduction, P = 0.023), graft/prosthesis/flap failure (60.5% reduction, P < 0.0001), ventilator greater than 48 hours (14.7% reduction, P = 0.012), superficial site infection (18.9% reduction P = 0.0005), and wound disruption (34.3% reduction, P = 0.011), according to the researchers. These improvements led to a net savings of nearly $2.2 million per 10,000 general and vascular procedures, according to the study. As ACS NSQIP collects only a sample of cases done, the implications for total costs avoided are much greater. It is estimated that 10,000 cases represents only about one fourth of the total general and vascular surgery cases done in the TSQC hospitals in 2009 and 2010. If the ACS NSQIP methodology were applied to all cases, the total costs avoided might be more than $8 million when comparing the results from 2010 with those from 2009.

According to the researchers, improvements in areas such as skin and soft tissue/wound disruption and ventilator management may be credited to the identification of a problem and rapid change in practice based upon evidence-based medicine.1 Improvements in renal and graft failure may be attributed to overall attention being focused on a problem that was uncovered through involvement in ACS NSQIP.

"While previous studies have shown that participation in quality improvement programs such as ACS NSQIP have been shown to save lives, improve health and reduce costs, the Tennessee collaborative illustrates that participation in an ACS NSQIP collaborative can accelerate those benefits and take quality improvement to a whole new level," said Oscar D. Guillamondegui, MD, MPH, FACS, lead author and associate professor of surgery at Vanderbilt University , Nashville.

As the health care system seeks to find ways to reduce costs, many hospitals and health care professionals are organizing themselves into "collaboratives" to work together to share best practices. The TSQC was formed in 2008 and is led by the Tennessee Chapter of the American College of Surgeons (TnACS) and the Tennessee Hospital Association with funding from the BlueCross BlueShield of Tennessee Health Foundation. The TSQC consists of Erlanger Hospital, Chattanooga; Vanderbilt University Hospital, Nashville; St. Francis Hospital, Memphis; Baptist Memorial Hospital, Memphis; Cookeville Regional Medical Center, Cookeville; Jackson Madison County General Hospital, Jackson; Johnson City Medical Center, Johnson City; Methodist University Hospital, Memphis; Parkwest Medical Center, Knoxville; and the University of Tennessee Medical Center, Knoxville.

ACS NSQIP collects patient and surgical procedure information, as well as 30-day postoperative outcomes. The results are reported semiannually to the participating sites, along with comparisons of the results from other health care facilities across the United States. There are currently more than 20 ACS NSQIP collaboratives in existence or in development, including collaboratives within systems and additional statewide collaborates in Florida and Oregon.

More information: 1 McGlynn, E.A., Intended and unintended consequences: what should we really worry about?Medical care, 2007. 45(1): p. 3-5.

Provided by Weber Shandwick Worldwide search and more info website

not rated yet  

Rank not rated yet
Relevant PhysicsForums posts

More news stories

Transvaginal mesh op restores pelvic organ prolapse at price

(HealthDay) -- Transvaginal mesh (TVM) procedures are effective for anatomical restoration of pelvic organ prolapse (POP), but patients report a worsening of sexual function following surgery, according to ...

Other created 12 hours ago | popularity not rated yet | comments 0

Tongue analysis software uses ancient Chinese medicine to warn of disease

For 5,000 years, the Chinese have used a system of medicine based on the flow and balance of positive and negative energies in the body. In this system, the appearance of the tongue is one of the measures used to classify ...

Other created May 25, 2012 | popularity 1 / 5 (1) | comments 0 | with audio podcast

Neck strength, cervical spine mobility don't predict pain

(HealthDay) -- Neither isometric neck muscle strength nor passive mobility of the cervical spine, two physical capacity parameters found to be associated with neck pain in other studies, predicts later neck ...

Other created May 25, 2012 | popularity not rated yet | comments 0

Pool access for the disabled sparks controversy

(AP) -- The Obama administration is sidestepping an election-year confrontation with the hotel industry and other pool owners to give them more time to comply with access rules for the disabled.

Other created May 25, 2012 | popularity not rated yet | comments 0

Chile to cover sex change operations

Chile will soon cover sex change surgeries under its public health plan in order to allow citizens of limited means to "recover their true sexual identity," Health Minister Jaime Manalich said.

Other created May 25, 2012 | popularity not rated yet | comments 0


Keep food safety in mind this memorial day weekend

(HealthDay) -- Picnics, parades and cookouts are as much a part of Memorial Day weekend as tributes to the United States' war veterans.

Travel to high altitudes tied to Crohn's, colitis flare-ups

(HealthDay) -- People with inflammatory bowel disease, which includes Crohn's disease and colitis, may be at increased risk for flare-ups when they fly or travel to high altitudes for skiing or mountain climbing, ...

Family history of Alzheimer's affects functional connectivity

(HealthDay) -- Cognitively normal individuals with a family history of late-onset Alzheimer's disease (AD) may display lower resting state functional connectivity in the default mode network (DMN) of the brain, ...

Of mice and mental models: Neuroscientific implications of risk-optimized behavior in the mouse

(Medical Xpress) -- Regardless of an organism’s biological complexity, every encephalized animal continuously makes under-informed behavioral choices that can have serious consequences. Despite its ubiquity, ...

Weight struggles? Blame new neurons in your hypothalamus

New nerve cells formed in a select part of the brain could hold considerable sway over how much you eat and consequently weigh, new animal research by Johns Hopkins scientists suggests in a study published in the May issue ...

Thioridazine kills cancer stem cells in human while avoiding toxic side-effects of conventional cancer treatments

A team of scientists at McMaster University has discovered a drug, thioridazine, successfully kills cancer stem cells in the human while avoiding the toxic side-effects of conventional cancer treatments.